Skip to content

Efficacy and safety of carbon dioxide fractional laser combined with minoxidil in the treatment of androgenetic alopecia

Efficacy and safety of carbon dioxide fractional laser combined with minoxidil in the treatment of androgenetic alopecia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070840
Enrollment
Unknown
Registered
2023-04-24
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

androgenetic alopecia

Interventions

Experimental group:Minoxidil combined with carbon dioxide fractional laser
Control group:Minoxidil

Sponsors

Tongji Hospital Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: The typical clinical picture is consistent with the diagnosis of AGA, the degree of hair loss is consistent with type M alopecia in the classification of androgenetic alopecia BASP, male patients aged 18 to 55 years; Patients with good general condition (no previous cardiac, systemic, scalp disease) who have not used any drugs (antihypertensive drugs, hormones, cytotoxic drugs, drugs with antiandrogen effects, etc.) that may affect hair growth within 3 months before the study; Patients who agree to participate in observation and follow-up, voluntarily sign informed consent forms, are willing to accept follow-up, and can cooperate closely throughout the process.

Exclusion criteria

Exclusion criteria: Patients with a history of systemic diseases within the past 6 months; Patients who have been treated with drugs that may affect the hair cycle within the past 3 months; Photosensitive patients and those who have undergone hair loss surgery such as hair transplantation.

Design outcomes

Primary

MeasureTime frame
Hair density;

Secondary

MeasureTime frame
Hair diameter;Patient subjective satisfaction evaluation;Dermatology Life Quality Index,DLQI;

Countries

China

Contacts

Public ContactJiang Miao

Tongji Hospital Affiliated to Tongji University

jiang-miao@126.com+86 13816151232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026